Compositions and methods for increasing lean muscle mass and/or reducing fat gain
    1.
    发明授权
    Compositions and methods for increasing lean muscle mass and/or reducing fat gain 有权
    用于增加瘦肌肉质量和/或减少脂肪增加的组合物和方法

    公开(公告)号:US09420808B2

    公开(公告)日:2016-08-23

    申请号:US13274597

    申请日:2011-10-17

    IPC分类号: A23K1/16 A23K1/18 A23L1/305

    摘要: Compositions and methods for increasing lean muscle mass and/or reducing fat gain in growing animals by feeding the animals a composition having a total lysine to metabolizable energy ratio of from about 2.5 to about 6 g/Mcal and comprising (a) arginine in a total arginine to total lysine ratio of from about 1.1 to about 1.6; (b) isoleucine in a total isoleucine to total lysine ratio of from about 0.8 to about 1.3; (c) leucine in a total leucine to total lysine ratio of from about 1.8 to about 3.0; (d) valine in a total valine to total lysine ratio of from about 0.8 to about 1.4; and (e) methionine and cystine in a total methionine plus cystine to total lysine ratio of from about 0.8 to about 1.7.

    摘要翻译: 通过向动物喂养具有约2.5至约6g / Mcal的总赖氨酸至可代谢能量比的组合物,并且包含(a)总共精氨酸,组合物和方法用于增加生长动物中的瘦肌肉质量和/或减少生长动物的脂肪增加 精氨酸与总赖氨酸的比例为约1.1至约1.6; (b)异亮氨酸与总赖氨酸的比例为约0.8至约1.3; (c)总亮氨酸与总赖氨酸比例为约1.8至约3.0的亮氨酸; (d)总缬氨酸与总赖氨酸的缬氨酸比为约0.8至约1.4; 和(e)蛋氨酸和胱氨酸在总蛋氨酸加上胱氨酸与总赖氨酸比例为约0.8至约1.7。

    Methods and compositions for the prevention and treatment of inflammatory diseases
    2.
    发明授权
    Methods and compositions for the prevention and treatment of inflammatory diseases 有权
    用于预防和治疗炎性疾病的方法和组合物

    公开(公告)号:US08388999B2

    公开(公告)日:2013-03-05

    申请号:US12823298

    申请日:2010-06-25

    IPC分类号: A23K1/17

    摘要: The invention provides compositions for preventing or treating inflammatory disease comprising one or more omega-3 fatty acids, one or more sulfur containing amino acids, and manganese and methods for preventing and treating inflammatory disease comprising administering such compositions to an animal susceptible to or suffering from inflammatory disease. In a preferred embodiment, the composition is admixed with one or more food ingredients to produce a food composition useful for preventing or treating inflammatory disease.

    摘要翻译: 本发明提供了用于预防或治疗炎性疾病的组合物,其包含一种或多种ω-3脂肪酸,一种或多种含硫氨基酸和锰,以及用于预防和治疗炎性疾病的方法,包括将所述组合物施用于易感或患有 炎性疾病。 在优选的实施方案中,将组合物与一种或多种食物成分混合以产生可用于预防或治疗炎性疾病的食物组合物。

    Compositions and Methods For Promoting Fat Loss
    4.
    发明申请
    Compositions and Methods For Promoting Fat Loss 失效
    促进脂肪减少的组合和方法

    公开(公告)号:US20100029768A1

    公开(公告)日:2010-02-04

    申请号:US12535893

    申请日:2009-08-05

    摘要: This invention provides diets useful for promoting fat loss in animals having a total lysine to metabolizable energy ratio of from about 6 to about 10 g/Mcal. This invention also provides compositions for promoting fat loss in animals, methods for preparing the compositions, methods for using the diets and compositions, articles of manufacture comprising the diets and compositions, and means for communicating information or instructions about such diets, compositions, methods, and articles of manufacture.

    摘要翻译: 本发明提供了用于促进具有约6至约10g / Mcal的总赖氨酸至可代谢能量比的动物中的脂肪减少的饮食。 本发明还提供用于促进动物脂肪减少的组合物,制备组合物的方法,使用饮食和组合物的方法,包含饮食和组合物的制品,以及用于传达关于这种饮食,组合物,方法, 和制品。

    Method for evaluating kidney function in a feline
    5.
    发明授权
    Method for evaluating kidney function in a feline 有权
    评估猫科动物肾功能的方法

    公开(公告)号:US07604954B2

    公开(公告)日:2009-10-20

    申请号:US11617015

    申请日:2006-12-28

    IPC分类号: G01N33/53

    CPC分类号: G01N33/74

    摘要: Methods for (1) evaluating feline kidney function by determining ghrelin level in feline tissue or biofluid and correlating the ghrelin level directly to kidney function and (2) diagnosing kidney disease in a feline comprises determining an observed ghrelin level in a tissue or biofluid of the feline and comparing the observed ghrelin level to a reference ghrelin level indicative of normal kidney function, wherein an observed level lower than the reference level is indicative of kidney disease or susceptibility thereto.

    摘要翻译: 方法(1)通过测定猫组织或生物流体中的生长素释放肽水平来评估猫肾功能,并将生长素释放肽水平与肾功能直接相关,和(2)诊断猫科动物中的肾脏疾病包括测定组织或生物流体中观察到的生长素释放肽水平 并将观察到的生长素释放肽水平与指示正常肾功能的参考生长素释放肽水平进行比较,其中低于参考水平的观察水平指示肾脏疾病或其易感性。